Although the LAG-3-FGL1 interaction mechanism remains unclear and controversial47, our results are consistent with recent reports that FGL1, serving as one ligand of LAG-315, inhibits the tumor immune microenvironment by accelerating T-cell exhaustion and blocking T-cell proliferation. Here, LAG3 is linked to neoplasm.